X.'s most recent trade in Alpha & Omega Semiconductor Ltd was a trade of 875 Common Share done at an average price of $34.0 . Disclosure was reported to the exchange on July 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpha & Omega Semiconductor Ltd | Bing Xue | EVP-WW Sales & Bus Development | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 16 Jul 2026 | 875 | 122,785 (0%) | 0% | 34.0 | 29,741 | Common Share |
| Aptargroup Inc | Julie Xing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2026 | 151 | 5,242 (0%) | 0% | 0 | Common Stock | |
| STAG Industrial Inc | Francis X. Jacoby | Director | Grant, award, or other acquisition of securities at price $ 38.89 per share. | 15 Jul 2026 | 417 | 34,225 (0%) | 0% | 38.9 | 16,217 | Common Stock |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 14 Jul 2026 | 23,634 | 252,594 | - | 0.3 | 8,036 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 23,634 | 166,532 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 14 Jul 2026 | 23,634 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 14 Jul 2026 | 7,878 | 7,878 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2026 | 6,278 | 1,600 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2026 | 1,600 | 0 | - | - | American Depositary Shares | |
| SharkNinja Inc | CJ Xuning Wang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.36 per share. | 10 Jul 2026 | 2,668,200 | 50,639,560 | - | 150.4 | 401,190,552 | Ordinary Shares |
| Paycom | William X. Kerber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2026 | 1,353 | 6,341 (0%) | 0% | 0 | Common Stock | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 23,554 | 77,923 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 07 Jul 2026 | 23,554 | 802,317 | - | 19.9 | 468,725 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 07 Jul 2026 | 23,554 | 825,871 | - | 4.7 | 110,704 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 07 Jul 2026 | 14,000 | 802,317 | - | 19.9 | 278,600 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 1,446 | 288,710 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 07 Jul 2026 | 1,446 | 802,317 | - | 19.9 | 28,775 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 07 Jul 2026 | 1,446 | 803,763 | - | 4.7 | 6,796 | Common Stock |
| NewMarket Corp | Ting Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 157 | 1,086 (0%) | 0% | 0 | Common Stock | |
| Badger Meter Inc | Xia Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 128 | 4,652 | - | - | Phantom Stock Units | |
| CaliberCos Inc (Class A) | Lawrence X. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 23,585 | 23,585 | - | - | Employee Stock Options (right to buy) | |
| Connect Biopharma Holdings Ltd (ADR) | Kleanthis G. Xanthopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 3,738 | 86,554 | - | 0 | Ordinary Shares | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 29 Jun 2026 | 7,400 | 98,589 | - | 3.0 | 22,422 | Common Stock |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 25 Jun 2026 | 23,634 | 252,594 | - | 0.3 | 8,036 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 23,634 | 190,166 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 25 Jun 2026 | 23,634 | 228,960 | - | 0 | Ordinary Shares | ||
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 25 Jun 2026 | 9,029 | 105,989 | - | 3.0 | 27,538 | Common Stock |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jun 2026 | 7,878 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 25 Jun 2026 | 7,878 | 7,878 | - | - | American Depositary Shares | ||
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 25 Jun 2026 | 2,127 | 115,018 | - | 3 | 6,381 | Common Stock |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Sale of securities on an exchange or to another person at price $ 276.26 per share. | 23 Jun 2026 | 1,292 | 0 (0%) | 0% | 276.3 | 356,927 | American Depositary Shares |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2026 | 743,529 | 4,625,693 | - | - | Stock Option (Right to Buy) | |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.97 per share. | 22 Jun 2026 | 743,529 | 1,869,032 | - | 10.0 | 7,412,984 | Common Stock |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.97 per share. | 22 Jun 2026 | 205,913 | 1,125,503 | - | 10.0 | 2,052,953 | Common Stock |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2026 | 205,913 | 5,369,222 | - | - | Stock Option (Right to Buy) | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.55 per share. | 22 Jun 2026 | 9,167 | 119,422 | - | 3.6 | 32,543 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.20 per share. | 22 Jun 2026 | 2,277 | 117,145 | - | 3.2 | 7,286 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Ramnik Xavier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 22,195 | 22,195 | - | - | Option to Buy | |
| Yum China Holdings Inc | Xueling Lu | Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 26 | 3,930 | - | - | Restricted Stock Unit | |
| Yum China Holdings Inc | Xueling Lu | Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 16 | 2,519 | - | - | Restricted Stock Unit | |
| Yum China Holdings Inc | Xueling Lu | Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 9 | 1,460 | - | - | Restricted Stock Unit | |
| Alpha & Omega Semiconductor Ltd | Bing Xue | EVP-WW Sales & Bus Development | Sale of securities on an exchange or to another person at price $ 47.09 per share. | 16 Jun 2026 | 4,916 | 123,660 (0%) | 0% | 47.1 | 231,494 | Common Share |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.18 per share. | 16 Jun 2026 | 3,613 | 129,102 | - | 3.2 | 11,489 | Common Stock |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Sale of securities on an exchange or to another person at price $ 266.76 per share. | 16 Jun 2026 | 1,357 | 0 (0%) | 0% | 266.8 | 361,997 | American Depositary Shares |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 16 Jun 2026 | 513 | 128,589 | - | 3.2 | 1,621 | Common Stock |
| Cava Grp Inc | Theodore Xenohristos | Director, Chief Concept Officer | Sale of securities on an exchange or to another person at price $ 89.43 per share. | 15 Jun 2026 | 3,252 | 324,630 | - | 89.4 | 290,826 | Common Stock |
| Meta | Tony Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 612 | 612 | - | - | Restricted Stock Units (RSU) (Class A) | |
| Koppers Holdings Inc | Feng Xudong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 34 | 411 | - | - | Dividend Equivalent Rights | |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 10,826 | 10,826 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 9,810 | 9,810 | - | - | Stock Option (Right to Buy) | |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.87 per share. | 12 Jun 2026 | 3,788 | 919,590 | - | 10.9 | 41,176 | Common Stock |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 229,775 | 229,775 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 193,492 | 193,492 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 118,625 | 1,308,161 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 99,892 | 4,682,493 (0%) | 0% | 0 | Ordinary Shares | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.94 per share. | 11 Jun 2026 | 12,996 | 136,381 | - | 3.9 | 51,204 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.58 per share. | 11 Jun 2026 | 3,666 | 132,715 | - | 3.6 | 13,124 | Common Stock |
| Cinemark Holdings Inc | Humrichouse G Ximena | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Jun 2026 | 3,503 | 51,783 (0%) | 0% | 0 | Common Stock | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 11 Jun 2026 | 1,462 | 149,377 | - | 4.1 | 6,023 | Common Stock |
| Fortinet | Jean X. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 650 | 0 | - | - | Restricted Stock Units | |
| Fortinet | Jean X. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 650 | 39,049 (0%) | 0% | 0 | Common Stock | |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Sale of securities on an exchange or to another person at price $ 261.20 per share. | 11 Jun 2026 | 626 | 0 (0%) | 0% | 261.2 | 163,512 | American Depositary Shares |
| Janus Intl Grp Inc (Class A) | Xavier A. Gutierrez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 20,912 | 85,937 | - | 0 | Common Stock | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 23,554 | 101,477 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.33 per share. | 08 Jun 2026 | 23,554 | 816,317 | - | 18.3 | 431,745 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 08 Jun 2026 | 23,554 | 839,871 | - | 4.7 | 110,704 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.33 per share. | 08 Jun 2026 | 14,000 | 816,317 | - | 18.3 | 256,620 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 08 Jun 2026 | 12,992 | 154,339 | - | 4.1 | 52,748 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 08 Jun 2026 | 5,893 | 167,331 | - | 4.4 | 25,811 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, Chairman, CEO and Interim CFO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.21 per share. | 08 Jun 2026 | 3,500 | 150,839 | - | 4.2 | 14,735 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 1,446 | 290,156 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.33 per share. | 08 Jun 2026 | 1,446 | 816,317 | - | 18.3 | 26,505 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 08 Jun 2026 | 1,446 | 817,763 | - | 4.7 | 6,796 | Common Stock |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Sale of securities on an exchange or to another person at price $ 269.33 per share. | 08 Jun 2026 | 1,444 | 40 (0%) | 0% | 269.3 | 388,916 | American Depositary Shares |
| BeiGene Ltd (ADR) | Xiaobin Wu | President and COO | Sale of securities on an exchange or to another person at price $ 270.55 per share. | 08 Jun 2026 | 40 | 0 (0%) | 0% | 270.6 | 10,822 | American Depositary Shares |
| Autoliv Inc | Xiaozhi Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2026 | 9 | 1,414 | - | - | Restricted Stock Unit | |
| CNB Fin Corp (PA) | Francis X. Straub | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 15,169 | 22,805 (0%) | 0% | 0 | Common Stock | |
| CNB Fin Corp (PA) | Francis X. Straub | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 5,250 | 5,250 (0%) | 0% | 0 | Depositary Shares | |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.74 per share. | 05 Jun 2026 | 4,449 | 924,637 | - | 10.7 | 47,782 | Common Stock |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.74 per share. | 05 Jun 2026 | 1,259 | 923,378 | - | 10.7 | 13,522 | Common Stock |
| Mercer Intl Inc | Eric X. Heine | VP Sales, Marketing& Logistics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 10,750 | 10,750 | - | - | Restricted Stock Units | |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2026 | 2,500 | 9,921,110 (5%) | 0% | 0 | Common Stock | |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2026 | 2,250 | 9,918,860 (5%) | 0% | 0 | Common Stock | |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2026 | 500 | 9,918,360 (5%) | 0% | 0 | Common Stock | |
| Koppers Holdings Inc | Feng Xudong | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 5,695 | 26,489 (0%) | 0% | 0 | Common Stock | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 03 Jun 2026 | 3,898 | 175,288 | - | 4.4 | 17,190 | Common Stock |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 146.55 per share. | 03 Jun 2026 | 2,337 | 9,924,306 (5%) | 0% | 146.6 | 342,488 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.26 per share. | 03 Jun 2026 | 2,323 | 179,186 | - | 4.3 | 9,896 | Common Stock |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 03 Jun 2026 | 2,064 | 173,224 | - | 4.4 | 9,123 | Common Stock |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 147.71 per share. | 03 Jun 2026 | 564 | 9,923,742 (5%) | 0% | 147.7 | 83,307 | Common Stock |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 144.46 per share. | 03 Jun 2026 | 464 | 9,927,053 (5%) | 0% | 144.5 | 67,029 | Common Stock |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 145.72 per share. | 03 Jun 2026 | 410 | 9,926,643 (5%) | 0% | 145.7 | 59,745 | Common Stock |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 148.30 per share. | 03 Jun 2026 | 132 | 9,923,610 (5%) | 0% | 148.3 | 19,576 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2026 | 155,000 | 461,470 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.90 per share. | 02 Jun 2026 | 155,000 | 53,133,004 (30%) | 0% | 22.9 | 3,549,500 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 144.29 per share. | 02 Jun 2026 | 39,854 | 53,063,642 (30%) | 0% | 144.3 | 5,750,542 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 146.36 per share. | 02 Jun 2026 | 37,540 | 53,013,281 (30%) | 0% | 146.4 | 5,494,422 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 143.43 per share. | 02 Jun 2026 | 19,867 | 53,103,496 (30%) | 0% | 143.4 | 2,849,597 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 148.24 per share. | 02 Jun 2026 | 18,492 | 52,980,999 (30%) | 0% | 148.2 | 2,741,162 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 147.37 per share. | 02 Jun 2026 | 13,790 | 52,999,491 (30%) | 0% | 147.4 | 2,032,297 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 145.04 per share. | 02 Jun 2026 | 12,821 | 53,050,821 (30%) | 0% | 145.0 | 1,859,551 | Common Stock |